Anti-Tuberculosis Therapy-Induced Hepatotoxicity among Ethiopian HIV-Positive and Negative Patients
Getnet Yimer, Getachew Aderaye, Wondwossen Amogne et al. · 2008
Read Anti-Tuberculosis Therapy-Induced Hepatotoxicity among Ethiopian HIV-Positive and Negative Patients by Getnet Yimer, Getachew Aderaye, Wondwossen Amogne et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0001809.txt.
Description
Getnet Yimer, Getachew Aderaye, Wondwossen Amogne, and their co-authors studied liver damage from tuberculosis drugs in Ethiopia in a 2008 PLOS ONE research article. Anti-tuberculosis therapy can injure the liver, a side effect called hepatotoxicity. The team set out to assess and compare its prevalence, severity, and prognosis in TB patients with and without HIV.
They enrolled 103 HIV-positive and 94 HIV-negative TB patients and evaluated all of them during treatment. The full text gives the liver injury rates and outcomes in each group. Co-infected patients take many drugs at once, so knowing whether HIV raises liver risk helps clinics schedule monitoring where it counts most.
Catalog record
| CREATOR | Getnet Yimer, Getachew Aderaye, Wondwossen Amogne et al. |
|---|---|
| YEAR | 2008 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 27 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0001809